Results

Total Results: 1,455 records

Showing results for "analyze".

21. Data Development for Patient Safety — A Pilot Study using Medicare Part B Drug Data | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/patient-safety-drug-data/abstract
    April 01, 2018 - the study of pharmaceuticals under investigation; and The formulation of statistical approaches to analyze

22. Cover Page (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
    September 01, 2007 - They determine that information technology tools that analyze administrative data recorded using ICD9 … Fisher et al., (1987) conducted a study to analyze the effectiveness of post-marketing surveillance … surveillance admin Initiate surveillance Collect baseline and follow-up data Contact FDA- ODS Analyze … We analyze each of these factors and identify the critical elements of the community pharmacy based … We then analyze the critical success factors for the DERMS-based post marketing surveillance mechanism

23. Cover Page (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - They determine that information technology tools that analyze administrative data recorded using ICD9 … Fisher et al., (1987) conducted a study to analyze the effectiveness of post-marketing surveillance … surveillance admin Initiate surveillance Collect baseline and follow-up data Contact FDA- ODS Analyze … We analyze each of these factors and identify the critical elements of the community pharmacy based … We then analyze the critical success factors for the DERMS-based post marketing surveillance mechanism

24. Handling Continuous Outcomes in Quantitative Synthesis | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/continuous-outcomes-quantitative-synthesis/methods
    December 01, 2019 - RCTs) for a comparative effectiveness review, continuous outcomes are usually less straightforward to analyze

25. App-E-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

26. Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/childhood-cancer-survivorship-care/research
    July 01, 2022 - We had two aims: (1) identify and analyze models of survivorship care for adult survivors of childhood

27. Disposition of Comments_CER 241: Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-241-wheelchair-users-disposition-comments.pdf
    October 18, 2022 - Most studies that met inclusion criteria did not report HR or RPE making it difficult to analyze results … Most studies that met inclusion criteria did not report HR or RPE making it difficult to analyze results

28. Diagnosis and Comparative Effectiveness of Treatments for Urinary Incontinence in Adult Women | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/urinary-incontinence-treatment/research-protocol
    December 01, 2020 - We will analyze the harmful effects of drugs from all sources including efficacy, effectiveness, and … We will analyze harms regardless of how authors perceived causality of the study treatments. … We will analyze urinary incontinence with the definitions of signs and symptoms of UI promoted by the … We will also analyze urinary continence defined as negative stress and pad tests. … We will analyze in logarithmic scale adjusted regression coefficient with standard error of association

29. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/effect-dietary-digestible/research
    March 01, 2025 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

30. Ced -Appendix-2 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    October 12, 2022 - CED proposal should include the end date for coverage by CED with time to analyze evidence gathered and … most recently made to the CED program in 2014, allowing for almost a decade of real-world examples to analyze … most recently made to the CED program in 2014, allowing for almost a decade of real-world examples to analyze … duration set for accrual of data CED proposal should include the end date for coverage by CED with time to analyze

31. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/carbohydrate-intake/draft-report
    March 01, 2025 - consumption patterns instead of isolated nutrients and using principal component analysis to categorize and analyze

32. Child and Adolescent Exposure to Trauma: Comparative Effectiveness of Interventions Addressing Trauma Other Than Maltreatment or Family Violence | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/trauma-child-interventions/research
    December 01, 2019 - We did not quantitatively analyze our data because of statistical heterogeneity, insufficient numbers

33. Training and Support for Patients and Consumers Engaged in Research (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/bonoff-text.pdf
    January 01, 2000 - methodology course to prepare advocates to serve on breast cancer decision-making bodies and to critically analyze

34. Slide 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_bonoff.pdf
    January 01, 2000 - methodology course to prepare advocates to serve on breast cancer decision-making bodies and to critically analyze

35. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

36. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

37. Cancer-Anemia-Update Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - 1 Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update Executive Summary Background Anemia, a deficiency in the concentration of hemoglobin-containing red blood cells, is prevalent among cancer patients, depending on the type of malignancy and t…

38. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…

39. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…

40. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…